Andere Sprachen PharmaCielo Ltd.

Aktien

A2PCAX

CA71716K1012

PCLO

Verzögert Toronto S.E. Andere Börsenplätze 16:29:07 07.05.2024			% 5 Tage	% 1. Jan.
0.155 ^CAD	-3.13%		-.--%	-13.89%

04.01.	Benuvia und PharmaCielo geben strategische Partnerschaft zur Herstellung von CBD-Isolat in pharmazeutischer Qualität nach cGMP und verwandten Produkten bekannt	CI
2023	PharmaCielo Ltd. meldet Ergebnis für das dritte Quartal und die neun Monate bis zum 30. September 2023	CI

Andere Sprachen

Erhalten Sie Zugang zu allen Nachrichten über alle Unternehmen: Verpassen Sie keine profitable Anlagechance mehr!

100% kostenlose Registrierung

Canadian Investment Regulatory Organization Trading Halt - PCLO	08.05.
PharmaCielo Announces Issuance of Failure to File Cease Trade Order	08.05.
PharmaCielo Signs Binding Letter of Intent to Acquire Operations in Thailand; Announces $2 Million Non-Brokered Private Placement with Participation from PharmaCielo Insiders and Siam Ventures Investors	10.04.
PharmaCielo Ltd. announced that it expects to receive CAD 2 million in funding	10.04.
PharmaCielo to Supply Ease Labs with Commercial Shipments of API to Fulfill Contract with State Government of Sao Paulo, Brazil	26.03.
Colombian Government Continues its Support of Domestic Cannabis Industry - Resolution Extending THC Inventory Allowance Provides Immediate Benefit to PharmaCielo	01.03.
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	04.01.
Benuvia and PharmaCielo Announce Strategic Partnership to Manufacture cGMP Pharmaceutical-Grade CBD Isolate and Related Products	04.01.
PharmaCielo Ltd. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2023	29.11.
PharmaCielo Announces Q3 2023 Financial Results	29.11.
PharmaCielo Raises $3.3 Million Under Non-Brokered Private Placement	06.10.23
PharmaCielo Raises $3.3 Million Under Previously Announced Non-Brokered Private Placement	06.10.23
PharmaCielo Ltd. announced that it has received CAD 4.78 million in funding	06.10.23
PharmaCielo Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2023	29.08.23
Pharmacielo Ltd. Appoints Marc Lustig as CEO	11.07.23
Pharmacielo Ltd. Announces Board Changes	11.07.23
PharmaCielo Ltd. announced that it expects to receive CAD 5 million in funding	29.06.23
PharmaCielo Ltd. announced that it has received CAD 12.825 million in funding	29.06.23
PharmaCielo Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	29.05.23
PharmaCielo Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	01.05.23

Keine Ergebnisse zu dieser Suche

Alle Nachrichten Analystenempfehlungen Wichtige Fakten Insiders Transkripte Pressemitteilungen Offizielle Publikationen Andere Sprachen Trading-Ideen MarketScreener Artikel MarketScreener Analysen

Andere Sprachen PharmaCielo Ltd.

Aktien

A2PCAX

CA71716K1012

PCLO

Andere Sprachen

Filter